apex pharm ltd Company Information
Company Number
08304463
Next Accounts
Sep 2025
Shareholders
tahir mahmood
amir waheed ikhlas
View AllGroup Structure
View All
Industry
Other human health activities
Registered Address
suite 1, 177 lees road, oldham, OL4 1JP
Website
www.apexpharmacy.co.ukapex pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of APEX PHARM LTD at £1.8m based on a Turnover of £4.1m and 0.43x industry multiple (adjusted for size and gross margin).
apex pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of APEX PHARM LTD at £348.8k based on an EBITDA of £104.7k and a 3.33x industry multiple (adjusted for size and gross margin).
apex pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of APEX PHARM LTD at £633.3k based on Net Assets of £269.6k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Apex Pharm Ltd Overview
Apex Pharm Ltd is a live company located in oldham, OL4 1JP with a Companies House number of 08304463. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2012, it's largest shareholder is tahir mahmood with a 33.3% stake. Apex Pharm Ltd is a established, small sized company, Pomanda has estimated its turnover at £4.1m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Apex Pharm Ltd Health Check
Pomanda's financial health check has awarded Apex Pharm Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs


5 Strong

1 Regular

4 Weak

Size
annual sales of £4.1m, make it larger than the average company (£797.3k)
- Apex Pharm Ltd
£797.3k - Industry AVG

Growth
3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (6.5%)
- Apex Pharm Ltd
6.5% - Industry AVG

Production
with a gross margin of 21%, this company has a higher cost of product (36.4%)
- Apex Pharm Ltd
36.4% - Industry AVG

Profitability
an operating margin of 2.6% make it less profitable than the average company (5.5%)
- Apex Pharm Ltd
5.5% - Industry AVG

Employees
with 27 employees, this is above the industry average (19)
27 - Apex Pharm Ltd
19 - Industry AVG

Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- Apex Pharm Ltd
£27k - Industry AVG

Efficiency
resulting in sales per employee of £152.2k, this is more efficient (£51.3k)
- Apex Pharm Ltd
£51.3k - Industry AVG

Debtor Days
it gets paid by customers after 96 days, this is later than average (22 days)
- Apex Pharm Ltd
22 days - Industry AVG

Creditor Days
its suppliers are paid after 138 days, this is slower than average (17 days)
- Apex Pharm Ltd
17 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Apex Pharm Ltd
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Apex Pharm Ltd
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 82.3%, this is a higher level of debt than the average (27.8%)
82.3% - Apex Pharm Ltd
27.8% - Industry AVG
APEX PHARM LTD financials

Apex Pharm Ltd's latest turnover from December 2023 is estimated at £4.1 million and the company has net assets of £269.6 thousand. According to their latest financial statements, Apex Pharm Ltd has 27 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | |||||||||||
Interest Receivable | |||||||||||
Pre-Tax Profit | |||||||||||
Tax | |||||||||||
Profit After Tax | |||||||||||
Dividends Paid | |||||||||||
Retained Profit | |||||||||||
Employee Costs | |||||||||||
Number Of Employees | 27 | 25 | 10 | 10 | 10 | 12 | |||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 441,648 | 364,184 | 373,143 | 385,098 | 368,693 | 319,939 | 17,019 | 8,665 | 10,128 | 10,915 | 8,792 |
Intangible Assets | |||||||||||
Investments & Other | |||||||||||
Debtors (Due After 1 year) | |||||||||||
Total Fixed Assets | 441,648 | 364,184 | 373,143 | 385,098 | 368,693 | 319,939 | 17,019 | 8,665 | 10,128 | 10,915 | 8,792 |
Stock & work in progress | 43,000 | 41,860 | 33,260 | ||||||||
Trade Debtors | 1,084,337 | 883,270 | 947,164 | 729,226 | 500,478 | 160,411 | 435,549 | 408,778 | 647 | ||
Group Debtors | |||||||||||
Misc Debtors | |||||||||||
Cash | 294,504 | 164,839 | 65,764 | ||||||||
misc current assets | |||||||||||
total current assets | 1,084,337 | 883,270 | 947,164 | 729,226 | 500,478 | 160,411 | 435,549 | 408,778 | 337,504 | 207,346 | 99,024 |
total assets | 1,525,985 | 1,247,454 | 1,320,307 | 1,114,324 | 869,171 | 480,350 | 452,568 | 417,443 | 347,632 | 218,261 | 107,816 |
Bank overdraft | |||||||||||
Bank loan | |||||||||||
Trade Creditors | 1,233,161 | 1,022,414 | 1,110,983 | 909,692 | 707,579 | 342,600 | 330,495 | 334,070 | 290,945 | 201,126 | 102,018 |
Group/Directors Accounts | |||||||||||
other short term finances | |||||||||||
hp & lease commitments | |||||||||||
other current liabilities | |||||||||||
total current liabilities | 1,233,161 | 1,022,414 | 1,110,983 | 909,692 | 707,579 | 342,600 | 330,495 | 334,070 | 290,945 | 201,126 | 102,018 |
loans | |||||||||||
hp & lease commitments | |||||||||||
Accruals and Deferred Income | |||||||||||
other liabilities | 23,230 | 33,991 | 44,415 | 50,000 | |||||||
provisions | |||||||||||
total long term liabilities | 23,230 | 33,991 | 44,415 | 50,000 | |||||||
total liabilities | 1,256,391 | 1,056,405 | 1,155,398 | 959,692 | 707,579 | 342,600 | 330,495 | 334,070 | 290,945 | 201,126 | 102,018 |
net assets | 269,594 | 191,049 | 164,909 | 154,632 | 161,592 | 137,750 | 122,073 | 83,373 | 56,687 | 17,135 | 5,798 |
total shareholders funds | 269,594 | 191,049 | 164,909 | 154,632 | 161,592 | 137,750 | 122,073 | 83,373 | 56,687 | 17,135 | 5,798 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | 2,532 | 1,962 | 1,752 | ||||||||
Amortisation | |||||||||||
Tax | |||||||||||
Stock | -43,000 | 1,140 | 8,600 | 33,260 | |||||||
Debtors | 201,067 | -63,894 | 217,938 | 228,748 | 340,067 | -275,138 | 26,771 | 408,778 | -647 | 647 | |
Creditors | 210,747 | -88,569 | 201,291 | 202,113 | 364,979 | 12,105 | -3,575 | 43,125 | 89,819 | 99,108 | 102,018 |
Accruals and Deferred Income | |||||||||||
Deferred Taxes & Provisions | |||||||||||
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | |||||||||||
Change in Investments | |||||||||||
cash flow from investments | |||||||||||
Financing Activities | |||||||||||
Bank loans | |||||||||||
Group/Directors Accounts | |||||||||||
Other Short Term Loans | |||||||||||
Long term loans | |||||||||||
Hire Purchase and Lease Commitments | |||||||||||
other long term liabilities | -10,761 | -10,424 | -5,585 | 50,000 | |||||||
share issue | |||||||||||
interest | |||||||||||
cash flow from financing | |||||||||||
cash and cash equivalents | |||||||||||
cash | -294,504 | 129,665 | 99,075 | 65,764 | |||||||
overdraft | |||||||||||
change in cash | -294,504 | 129,665 | 99,075 | 65,764 |
apex pharm ltd Credit Report and Business Information
Apex Pharm Ltd Competitor Analysis

Perform a competitor analysis for apex pharm ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in OL4 area or any other competitors across 12 key performance metrics.
apex pharm ltd Ownership
APEX PHARM LTD group structure
Apex Pharm Ltd has no subsidiary companies.
Ultimate parent company
APEX PHARM LTD
08304463
apex pharm ltd directors
Apex Pharm Ltd currently has 3 directors. The longest serving directors include Mr Amir Ikhlas (Nov 2012) and Mr Mohammed Shahzad (Nov 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Amir Ikhlas | United Kingdom | 39 years | Nov 2012 | - | Director |
Mr Mohammed Shahzad | England | 42 years | Nov 2012 | - | Director |
Mr Tahir Mahmood | England | 44 years | Jan 2018 | - | Director |
P&L
December 2023turnover
4.1m
+26%
operating profit
104.7k
0%
gross margin
21.1%
+3.81%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
269.6k
+0.41%
total assets
1.5m
+0.22%
cash
0
0%
net assets
Total assets minus all liabilities
apex pharm ltd company details
company number
08304463
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
November 2012
age
13
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
suite 1, 177 lees road, oldham, OL4 1JP
Bank
-
Legal Advisor
-
apex pharm ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to apex pharm ltd.
apex pharm ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for APEX PHARM LTD. This can take several minutes, an email will notify you when this has completed.
apex pharm ltd Companies House Filings - See Documents
date | description | view/download |
---|